Johannes Levin, MD, is Chief Medical Officer at MODAG GmbH, which he joined in 2019. Dr. Levin was previously head of the Outpatient Clinic for Neurodegenerative Diseases at the Department of Neurology at the Ludwig-Maximilian-University (LMU) and deputy head of clinical research at the German Center for Neurodegenerative Diseases (DZNE) and continues half time in both of those roles. He has served as principal investigator on many clinical studies including the largest interventional multiple system atrophy (MSA) trial in Germany and international cohort studies such as the Dominantly Inherited Alzheimer’s Network (DIAN).
Dr. Levin studied medicine at LMU Munich, Universidad de Granada (Spain) and Harvard Medical School. He holds a Doctor of Medicine from LMU. Dr. Levin is a board-certified neurologist at the Bavarian Chamber of Physicians and has published over 110 scientific papers. His work has contributed to the definition of the natural history and treatment of neurodegenerative diseases.